• 0
MENU
Cart Details

Erbitux 5mg/ml Solution for Infusion

  • Home
  • Erbitux 5mg/ml Solution for Infusion

Product Informations: Erbitux 5mg/ml Solution for Infusion

In Head and neck cancer Head and neck cancer includes cancer of the mouth, nose, sinuses or throat. Erbitux 5mg/ml Solution for Infusion kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is a potent and very toxic medicine and you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol or smoking while having this treatment and drink plenty of water to stay hydrated. In Cancer of colon and rectum Cancer of the colon and rectum, also known as colorectal cancer (CRC) or bowel cancer, is the development of cancer from two parts of the large intestine, namely, the colon or rectum. In this type of cancer, the person may notice symptoms such as blood in the stool, a change in bowel movements, weight loss, and fatigue. Erbitux 5mg/ml Solution for Infusion treats and also lowers the risk of developing further cancerous growths (polyps) and bowel cancer. It kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is an effective medicine, but has some bothersome side effects. Consult your doctor if you have any concerns.

Your doctor or nurse will give you this medicine. Kindly do not self-administer.
Erbitux 5mg/ml Solution for Infusion is used in the treatment of head and neck cancer and cancer of colon and rectum. It helps to mark the cancer cells for destruction by the body's immune system. Erbitux 5mg/ml Solution for Infusion is given as an injection under the supervision of a doctor. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. Do not stop taking it unless your doctor tells you to. The most common side effects of this medicine include nausea, headache, vomiting, and skin rash. If these bother you or appear serious, let your doctor know. There may be ways of reducing or preventing them. Inform your doctor if you experience sudden difficulty in breathing, shortness of breath, fever, or chills. Regular blood tests are required to check your blood cells along with heart, liver, and electrolyte levels. It makes your skin more sun-sensitive, take precaution while stepping out. Before taking it, tell your doctor if you have heart disease, or kidney problems or are taking any medicines to treat infections. Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.
  • Headache
  • Vomiting
  • Conjunctivitis
  • Skin rash
  • Diarrhea
  • Infusion reaction
  • Decreased magnesium level in blood
  • Increased liver enzymes
Alcohol : CONSULT YOUR DOCTOR

It is not known whether it is safe to consume alcohol with Erbitux 5mg/ml Solution for Infusion. Please consult your doctor.

Pregnancy : CONSULT YOUR DOCTOR

Erbitux 5mg/ml Solution for Infusion may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Breast feeding : CONSULT YOUR DOCTOR

Erbitux 5mg/ml Solution for Infusion is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.

Driving : UNSAFE

Erbitux 5mg/ml Solution for Infusion may cause side effects which could affect your ability to drive.

Kidney : SAFE IF PRESCRIBED

Erbitux 5mg/ml Solution for Infusion is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Erbitux 5mg/ml Solution for Infusion may not be needed in these patients. Please consult your doctor.

Liver : CONSULT YOUR DOCTOR

There is limited information available on the use of Erbitux 5mg/ml Solution for Infusion in patients with liver disease. Please consult your doctor.

If you miss a dose of Erbitux 5mg/ml Solution for Infusion, please consult your doctor.

Chemical Class::Monoclonal antibody (mAb)|Habit Forming::No|Therapeutic Class::ANTI NEOPLASTICS|Action Class::EGFR (ErbB1 or HER1) inhibitors- Monoclonal antibody
  • Q. Q. Is Erbitux 5mg/ml Solution for Infusion a chemotherapy drug??
    Ans: Yes, Erbitux 5mg/ml Solution for Infusion is a cytotoxic drug that is used in the chemotherapy of cancers of colon and rectum, and head-neck cancers.
  • Q. Q. Is Erbitux 5mg/ml Solution for Infusion cytotoxic agent or vesicant or radiosensitizer??
    Ans: It is not a radiosensitizer, but usually used in combination with radiotherapy to treat the cancers. It is not a vesicant (irritant).
  • Q. Q. How is Erbitux 5mg/ml Solution for Infusion administered??
    Ans: Erbitux 5mg/ml Solution for Infusion is generally administered by intravenous (IV infusion) route, with or without radiotherapy.
  • Q. Q. Does Erbitux 5mg/ml Solution for Infusion cause hair loss??
    Ans: Yes. Erbitux 5mg/ml Solution for Infusion is a chemotherapy agent, which may cause hair loss. Please consult your doctor if you experience such side effect.
  • Q. Q. Why does Erbitux 5mg/ml Solution for Infusion cause a rash??
    Ans: Erbitux 5mg/ml Solution for Infusion may cause a rash. Consult your doctor if it bothers you.
  • Q. Q. How long does the rash last??
    Ans: The duration of skin rash depends upon its type and severity. Please consult your doctor for advice..

FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra


Alternatives and Substitutes


Customer Reviews

No customer reviews yet.

References

FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More

European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More

ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More

Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More


All Substitutes Product.


Available options.

Same salt composition: Cetuximab (5mg/ml)

Test Buy medical disposable face mask
to protect your loved ones